FDA calls out 39 drug companies for allegedly blocking access to generics
(By Erin Mershon for ST A T) Johnson & Johnson’s Actelion Pharmaceuticals, Celgene, and Gilead Life Sciences are all potentially
Read More
FDA
How A Drugmaker Gamed The System To Keep Generic Competition Away
(By Alison Kodjak for NPR) When Celgene Corp. first started marketing the drug Revlimid to treat multiple myeloma in 2006,
Read MoreIn a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal
(By Lev Facher for ST A T) WASHINGTON — The Food and Drug Administration on Wednesday approved for the first
Read MoreFederal kickback law might be used to bring down drug prices, FDA commissioner suggests
(By Ike Swetlitz for ST A T) WASHINGTON — The commissioner of the Food and Drug Administration, Scott Gottlieb, on
Read MoreDEA plan to stem supply of prescription drugs draws skepticism
(By Lev Facher for ST A T) WASHINGTON — With pressure building on the the Drug Enforcement Administration to stem
Read MoreStudy: Nearly Three-Quarters Of Commonly Used Medical Scopes Tainted By Bacteria
(By Chad Terhune for California Healthline produced by Kaiser Health News) In an ominous sign for patient safety, 71 percent
Read MoreFDA Launches Criminal Investigation Into Unauthorized Herpes Vaccine Research
(By Marisa Taylor for Kaiser Health News) The Food and Drug Administration has launched a criminal investigation into research by
Read MoreIn bid to lower prices, Gottlieb says FDA will take new action to speed approval of biosimilars
(By Adam Feuerstein for ST A T) NEW YORK — Scott Gottlieb, the commissioner of the Food and Drug Administration,
Read MoreDisposal of Unused Medicines: What You Should Know
(Source - www.fda.gov) Medicines play an important role in treating many conditions and diseases and when they are no longer
Read MoreGenetic tests ordered by doctors race to market, while ‘direct-to-consumer’ tests hinge on FDA approval
(By Ike Swetlitz for ST A T) WASHINGTON — The Food and Drug Administration is keeping tight watch on “direct-to-consumer”
Read More